Oftensin (Timolol)

Timolol, the active ingredient in Oftensin, is a beta‑blocker presented as a topical ophthalmic solution for intra‑ocular pressure reduction in patients with ocular hypertension or glaucoma. It works by decreasing aqueous humor production, thereby helping to control eye pressure and prevent optic nerve damage.

GNH USA supplies Oftensin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Timolol is used in ophthalmology to manage conditions that involve elevated intra‑ocular pressure. - Primary open‑angle glaucoma: lowers the risk of progressive vision loss by reducing eye pressure. - Ocular hypertension: helps to maintain target intra‑ocular pressure and delay onset of glaucoma. - Secondary secondary glaucoma (e.g., pigment pigment dispersion): provides adjunct pressure control when other therapies are insufficient. - Post‑operative post‑surgical eye care after laser or surgical procedures to prevent pressure spikes in the early recovery phase.

Timolol may cause a range of ocular and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation in the eye. - Temporary blurred vision. - Dry eye or mild irritation. - Reduced tear production. - Mild headache. - Transient fatigue.

Serious or Rare Side Effects: - Significant reduction in heart rate (bradycardia). - Marked drop in blood pressure (hypotension). - Bronchospasm in patients with asthma or chronic obstructive pulmonary disease. - Severe allergic reaction (anaphylaxis) with swelling, rash, or difficulty breathing. - Persistent visual disturbances. - Cardiac conduction abnormalities.

When using Timolol eye drops, patients and clinicians should consider several safety measures. - Assess cardiovascular status: check for bradycardia, heart block, or heart failure before initiating therapy. - Review respiratory health: avoid in patients with asthma or severe COPD. - Monitor for systemic absorption: watch for signs of beta‑blocker systemic effects, especially in the elderly. - Caution in diabetic patients: beta‑blockade may mask hypoglycaemic symptoms. - Avoid concurrent use with other ocular beta‑blockers unless directed by a specialist. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Timolol can interact with several systemic and ocular medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective non‑dosed    -    non‑dosed  ... -  Calcium  ...  ...  ...  ...  ...  ...  ...  ...  ...   -  Other  ...   ...  ... 

Moderate  ...  ...  ...  ...  ...  ...  ...  -  ");